Bristol-Myers Squibb buys festinavir, new NRTI active against MDR HIV
Prompt treatment and better screening could prevent many cancer deaths in patients taking HIV therapy
Lopinavir/ritonavir monotherapy a possible second-line option for treatment experienced children
Male partner involvement in PMTCT reduces HIV transmission risk
European recommendations issued on acute hepatitis C infection in patients with HIV
Once-daily darunavir approved for some treatment-experienced patients in US
Tenofovir with 3TC or FTC associated with lower lipid increases than other NRTI pairs
High triglycerides increase risk of neuropathy for patients with HIV
Stem cell transplant has cured HIV infection in 'Berlin patient', say doctors
